| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1657 |
| Trial ID | NCT02935543 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Phase2 |
| Recruitment status | Terminated |
| Title | CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL |
| Year | 2016 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | UPCC39416, 825668 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||